Skip to main content
. Author manuscript; available in PMC: 2015 Jan 15.
Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec 3;0:225–232. doi: 10.1016/j.jchromb.2013.11.054

Table 6. DTG Assay Selectivity in the Presence of Concomitant Medications.

DTG

Drug Name Mean % of LQC
didanosine (ddI) 103.7
stavudine (d4T) 103.0
lamivudine (3TC) 109.0
zalcitibine (ddC) 102.7
zidovudine (AZT) 101.2
abacavir (ABV) 104.2
tenofovir (TFV) 99.3
emtricitabine (FTC) 100.7
nevirapine (NVP 100.2
efavirenz (EFV) 102.7
etravirine (ETV) 104.0
amprenavir (APV) 97.3
indinavir (IDV) 102.5
darunavir (DRV) 94.5
saquinavir (SQV) 104.7
atazanavir (ATV) 108.2
lopinavir (LPV) 99.0
ritonavir (RTV) 105.0
nelfinavir (NFV) 99.0
maraviroc (MVC) 102.2
raltegravir (RAL) 102.5
acyclovir (ACV) 106.7
ganciclovir (GCV) 101.0